Cargando…

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders

BACKGROUND: The nonselective 5-HT(4) receptor agonists, cisapride and tegaserod have been associated with cardiovascular adverse events (AEs). AIM: To perform a systematic review of the safety profile, particularly cardiovascular, of 5-HT(4) agonists developed for gastrointestinal disorders, and a n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tack, J, Camilleri, M, Chang, L, Chey, W D, Galligan, J J, Lacy, B E, Müller-Lissner, S, Quigley, E M M, Schuurkes, J, Maeyer, J H, Stanghellini, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491670/ https://www.ncbi.nlm.nih.gov/pubmed/22356640 http://dx.doi.org/10.1111/j.1365-2036.2012.05011.x

Ejemplares similares

Radiosynthesis and preclinical evaluation of [(11)C]prucalopride as a potential agonist PET ligand for the 5-HT(4) receptor
por: Buiter, Hans JC, et al.
Publicado: (2013)

Diagnosis and treatment of chronic constipation – a European perspective
por: Tack, J, et al.
Publicado: (2011)

Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation
por: Wong, Banny S, et al.
Publicado: (2010)

Effect of the 5-HT(4) receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract
por: Nedi, Teshome, et al.
Publicado: (2018)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

Systematic review of definitions and outcome measures for return of bowel function after gastrointestinal surgery
por: Chapman, S. J., et al.
Publicado: (2018)

Randomized clinical trial: effect of the 5-HT(4) receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment
por: Tack, J, et al.
Publicado: (2015)

The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review
por: Moayyedi, Paul, et al.
Publicado: (2015)

Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy
por: Shaheen, N. J., et al.
Publicado: (2015)

A single channel mutation alters agonist efficacy at 5-HT(3)A and 5-HT(3)AB receptors
por: Thompson, A J, et al.
Publicado: (2013)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties
por: Beattie, David T., et al.
Publicado: (2011)

Dibenzofuranylethylamines as 5-HT(2A/2C) Receptor Agonists
por: Yempala, Thirumal, et al.
Publicado: (2020)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

Defining indocyanine green fluorescence to assess anastomotic perfusion during gastrointestinal surgery: systematic review
por: Slooter, M D, et al.
Publicado: (2021)

Delay to surgery in acute perforated and ischaemic gastrointestinal pathology: a systematic review
por: Murray, V, et al.
Publicado: (2021)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis
por: Ferraz Barbosa, Bárbara, et al.
Publicado: (2023)

A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection
por: Hawkings, Michael J., et al.
Publicado: (2023)

Meta‐analysis of the oncological safety of autologous fat transfer after breast cancer
por: Krastev, T. K., et al.
Publicado: (2018)

Gastrointestinal Stromal Tumours (GIST) of the Rectum: A Systematic Review and Meta-Analysis
por: Khan, Shaheer I., et al.
Publicado: (2022)

Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials
por: Camilleri, Michael, et al.
Publicado: (2016)

Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials
por: Shah, Eric D., et al.
Publicado: (2021)

Cardiovascular risk scores do not account for the effect of treatment: a review
por: Liew, S M, et al.
Publicado: (2011)

What is the value and impact of quality and safety teams? A scoping review
por: White, Deborah E, et al.
Publicado: (2011)

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
por: Gardiner, Kyle M., et al.
Publicado: (2018)

Randomised study: effects of the 5‐HT(4) receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis
por: Chedid, Victor, et al.
Publicado: (2021)

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide
por: Hungin, A P S, et al.
Publicado: (2013)

Systematic review: probiotics in the management of lower gastrointestinal symptoms – an updated evidence‐based international consensus
por: Hungin, A. P. S., et al.
Publicado: (2018)

Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance
por: Jain, Akshay B., et al.
Publicado: (2020)

Health Economic Research Assessing the Value of Early Detection of Cardiovascular Disease: A Systematic Review
por: Oude Wolcherink, Martijn J., et al.
Publicado: (2023)

Characterization of the 5-HT(2C) receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity
por: Higgins, Guy A, et al.
Publicado: (2015)

Lasmiditan mechanism of action – review of a selective 5-HT(1F) agonist
por: Clemow, David B., et al.
Publicado: (2020)

The Effect of Pre-Exercise Hyperhydration on Exercise Performance, Physiological Outcomes and Gastrointestinal Symptoms: A Systematic Review
por: Jardine, William T., et al.
Publicado: (2023)

Efficacy and safety of CPAP in low- and middle-income countries
por: Thukral, A, et al.
Publicado: (2016)

Long-term major adverse cardiovascular events following myocardial injury after non-cardiac surgery: meta-analysis
por: Strickland, Scarlett S, et al.
Publicado: (2023)

Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases
por: Zhu, Ye, et al.
Publicado: (2019)

Effect of Selective 5-HT6R Agonist on Expression of 5-HT Receptor and Neurotransmitter in Vascular Dementia Rats
por: Yu, Haining, et al.
Publicado: (2017)

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT(1A) Receptor Partial Agonist/5-HT(6) Receptor Full Agonist
por: Liu, Wen-Gang, et al.
Publicado: (2021)

Cardiorespiratory Fitness in Childhood and Adolescence Affects Future Cardiovascular Risk Factors: A Systematic Review of Longitudinal Studies
por: Mintjens, Stijn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_48ed7eand1vp75va63hska1pi6